If you liked this article you might like

Insiders Love Bioverativ, Juno Therapeutics and More
One of the World's Largest Private Equity Firms Has Seen Its Stock Soar - Now What?
Jim Cramer: Radius Health Is a Takeover Target
Amgen Osteoporosis Drug Approval Plan Derailed Over Heart Safety Risk -- Jim Cramer Weighs In